TUESDAY Feb. 4, 2014, 2014 -- In a first-of-its-kind initiative, the U.S. National Institutes of Health has partnered with 10 drug companies and several nonprofit groups to speed development of biological ways of diagnosing and treating ...
Rheumatoid arthritis patients can generally look forward to a much better quality of life today than they did 20 years ago, new research suggests. The observation is based on a comparative multi-year tracking of more than 1,100 rheumatoid ...
Japanese firms Ono Pharma and Bristol-Myers KK (BMKK) have rolled out the rheumatoid arthritis drug, Orencia Subcutaneous Injection 125mg Syringe 1ml, in Japan. Orencia SC, whose generic name is abatacept, restrains the discharge of ...
Astellas Pharma and UCB have introduced Cimzia (certolizumab pegol) rheumatoid arthritis therapy in Japan. The PEGylated Fc-free anti-TNF medication is indicated for adult rheumatoid arthritis patients who showed poor response to ...
Tags: Astellas Pharma, Astellas, rheumatoid arthritis therapy
Antares Pharma has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Otrexup, a combination product to deliver methotrexate methotrexate (MTX) using Medi-Jet technology. Antares Pharma president ...
Tags: NDA, FDA, medical technology